Kim Jun Sung, Park Won Cheol, Lee Joo Hyun
Department of Surgery, Wonkwang University Hospital, Wonkwang University School of Medicine, Iksan, Korea.
Ann Coloproctol. 2019 Aug;35(4):181-186. doi: 10.3393/ac.2018.10.18. Epub 2019 Aug 31.
This study aimed to compare the short-term outcomes of laparoscopic-assisted colon cancer surgery in the Soloassist II-assisted (SA) group and in the human-assisted (HA) group.
A total of 76 patients with colon cancer who underwent laparoscopic-assisted right hemicolectomy and anterior resection performed by a single surgeon between January 2017 and May 2018 were recruited from the consecutively enrolled registry and retrospectively analyzed.
Of 76 patients, 43 underwent surgery with human assistance and 33 underwent surgery using the Soloassist II system. The clinicopathologic characteristics were not statistically different between the 2 groups. In both HA and SA groups, no statistical difference was observed between operation time (220.23 ± 47.83 minutes vs. 218.03 ± 38.22 minutes, P = 0.829), total number of harvested lymph nodes (20.42 ± 10.86 vs. 20.24 ± 8.21, P = 0.938), and other parameters of short-term outcomes (length of hospital stay, blood loss, open conversion, time to flatus, time to soft diet, and complication events). Subgroup analyses did not show statistical differences.
Soloassist II can reduce the participation of a human assistant during surgery and is not inferior to human assistance in laparoscopic-assisted colon cancer surgery. Thus, it is a feasible instrument in laparoscopic-assisted colon cancer surgery that can provide positive short-term outcomes.
本研究旨在比较Soloassist II辅助(SA)组和人工辅助(HA)组腹腔镜辅助结肠癌手术的短期疗效。
从连续登记的病例中选取2017年1月至2018年5月间由同一外科医生进行腹腔镜辅助右半结肠切除术和前切除术的76例结肠癌患者,并进行回顾性分析。
76例患者中,43例接受人工辅助手术,33例使用Soloassist II系统进行手术。两组的临床病理特征无统计学差异。在HA组和SA组中,手术时间(220.23±47.83分钟对218.03±38.22分钟,P = 0.829)、清扫淋巴结总数(20.42±10.86对20.24±8.21,P = 0.938)以及其他短期疗效参数(住院时间、失血量、中转开腹、排气时间、进软食时间和并发症发生率)均无统计学差异。亚组分析也未显示出统计学差异。
Soloassist II可减少手术中人工助手的参与,在腹腔镜辅助结肠癌手术中并不逊色于人工辅助。因此,它是一种可行的腹腔镜辅助结肠癌手术器械,能带来良好的短期疗效。